Novartis gets FDA approval for combo pill valturna to treat high BP
Saturday, September 19, 2009 10:00 IST Basel
The US Food and Drug Administration (FDA) has approved Valturna (aliskiren and valsartan) tablets, the first and only medicine to target two key points within the renin system
